Regent Pacific Group Limited (FRA:RPG)

Market Cap	31.36M
Revenue (ttm)	709.30K
Net Income (ttm)	-3.47M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,000
Average Volume	9,106
Open	0.1020
Previous Close	0.1020
Day's Range	0.1020 - 0.1020
52-Week Range	0.0345 - 0.1270
Beta	n/a
RSI	55.89
Earnings Date	Nov 28, 2025

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog...

• Industry: Investors, not elsewhere classified
• Founded: 1991
• Employees: 17
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RPG

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.

Financial numbers in USD